Anoctamin 1 dysregulation alters bronchial epithelial repair in cystic fibrosis

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1832, Issue 12, 2013, Pages 2340-2351

  Ruffin, Manon ^a,b   Voland, Mélanie ^a,b   Marie, Solenne ^a,b   Bonora, Monique ^a,b   Blanchard, Elise ^a,b   Blouquit Laye, Sabine ^c,d   Naline, Emmanuel ^c,d   Puyo, Philippe ^e   Le Rouzic, Philippe ^a,b   Guillot, Loic ^a,b   Corvol, Harriet ^a,b,f   Clement, Annick ^a,b,f   Tabary, Olivier ^a,b  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c UPRES EA 220   (France)

^d LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^e FOCH HOSPITAL   (France)

^f ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Airway; Anoctamin 1; Bronchial epithelial repair; Cell proliferation; Cystic fibrosis; TMEM16a

Indexed keywords

ANOCTAMIN 1; MEMBRANE PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRONCHUS MUCOSA; CELL LINE; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYSTIC FIBROSIS; EPITHELIUM CELL; EXPLANT; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE; WOUND HEALING;

EID: 84885118885     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2013.09.012     Document Type: Article

References (55)

1. Jacquot J., Tabary O., Le Rouzic P., Clement A. Airway epithelial cell inflammatory signalling in cystic fibrosis. Int. J. Biochem. Cell Biol. 2008, 40:1703-1715.
2. Hajj R., Lesimple P., Nawrocki-Raby B., Birembaut P., Puchelle E., Coraux C. Human airway surface epithelial regeneration is delayed and abnormal in cystic fibrosis. J. Pathol. 2007, 211:340-350.
3. Voynow J.A., Fischer B.M., Roberts B.C., Proia A.D. Basal-like cells constitute the proliferating cell population in cystic fibrosis airways. Am. J. Respir. Crit. Care Med. 2005, 172:1013-1018.
4. Maille E., Trinh N.T., Prive A., Bilodeau C., Bissonnette E., Grandvaux N., Brochiero E. Regulation of normal and cystic fibrosis airway epithelial repair processes by TNF-alpha after injury. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 301:L945-L955.
5. Trinh N.T., Bardou O., Prive A., Maille E., Adam D., Lingee S., Ferraro P., Desrosiers M.Y., Coraux C., Brochiero E. Improvement of defective cystic fibrosis airway epithelial wound repair after CFTR rescue. Eur. Respir. J. 2012, 40:1390-1400.
6. Cross N.L. Initiation of the activation potential by an increase in intracellular calcium in eggs of the frog, Rana pipiens. Dev. Biol. 1981, 85:380-384.
7. Schlichter L.C., Elinson R.P. Electrical responses of immature and mature Rana pipiens oocytes to sperm and other activating stimuli. Dev. Biol. 1981, 83:33-41.
8. Frizzell R.A., Rechkemmer G., Shoemaker R.L. Altered regulation of airway epithelial cell chloride channels in cystic fibrosis. Science 1986, 233:558-560.
9. Paradiso A.M., Ribeiro C.M., Boucher R.C. Polarized signaling via purinoceptors in normal and cystic fibrosis airway epithelia. J. Gen. Physiol. 2001, 117:53-67.
10. Clarke L.L., Boucher R.C. Chloride secretory response to extracellular ATP in human normal and cystic fibrosis nasal epithelia. Am. J. Physiol. 1992, 263:C348-C356.
11. Knowles M.R., Clarke L.L., Boucher R.C. Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis. N. Engl. J. Med. 1991, 325:533-538.
12. Accurso F.J., Moss R.B., Wilmott R.W., Anbar R.D., Schaberg A.E., Durham T.A., Ramsey B.W. Denufosol tetrasodium in patients with cystic fibrosis and normal to mildly impaired lung function. Am. J. Respir. Crit. Care Med. 2011, 183:627-634.
13. Ratjen F., Durham T., Navratil T., Schaberg A., Accurso F.J., Wainwright C., Barnes M., Moss R.B. Long term effects of denufosol tetrasodium in patients with cystic fibrosis. J. Cyst. Fibros. 2012, 11:539-549.
14. Becq F., Mall M.A., Sheppard D.N., Conese M., Zegarra-Moran O. Pharmacological therapy for cystic fibrosis: from bench to bedside. J. Cyst. Fibros. 2011, 10(Suppl. 2):S129-S145.
15. Caputo A., Caci E., Ferrera L., Pedemonte N., Barsanti C., Sondo E., Pfeffer U., Ravazzolo R., Zegarra-Moran O., Galietta L.J. TMEM16A, a membrane protein associated with calcium-dependent chloride channel activity. Science 2008, 322:590-594.
16. Schroeder B.C., Cheng T., Jan Y.N., Jan L.Y. Expression cloning of TMEM16A as a calcium-activated chloride channel subunit. Cell 2008, 134:1019-1029.
17. Yang Y.D., Cho H., Koo J.Y., Tak M.H., Cho Y., Shim W.S., Park S.P., Lee J., Lee B., Kim B.M., Raouf R., Shin Y.K., Oh U. TMEM16A confers receptor-activated calcium-dependent chloride conductance. Nature 2008, 455:1210-1215.
18. Schreiber R., Uliyakina I., Kongsuphol P., Warth R., Mirza M., Martins J.R., Kunzelmann K. Expression and function of epithelial anoctamins. J. Biol. Chem. 2010, 285:7838-7845.
19. Huang F., Rock J.R., Harfe B.D., Cheng T., Huang X., Jan Y.N., Jan L.Y. Studies on expression and function of the TMEM16A calcium-activated chloride channel. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:21413-21418.
20. Fischer H., Illek B., Sachs L., Finkbeiner W.E., Widdicombe J.H. CFTR and calcium-activated chloride channels in primary cultures of human airway gland cells of serous or mucous phenotype. Am. J. Physiol. Lung Cell. Mol. Physiol. 2010, 299:L585-L594.
21. - secretory channel in mouse airways. J. Biol. Chem. 2009, 284:14875-14880.
22. +-dependent chloride transport. J. Biol. Chem. 2009, 284:28698-28703.
23. Huang F., Zhang H., Wu M., Yang H., Kudo M., Peters C.J., Woodruff P.G., Solberg O.D., Donne M.L., Huang X., Sheppard D., Fahy J.V., Wolters P.J., Hogan B.L., Finkbeiner W.E., Li M., Jan Y.N., Jan L.Y., Rock J.R. Calcium-activated chloride channel TMEM16A modulates mucin secretion and airway smooth muscle contraction. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:16354-16359.
24. +/calmodulin. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:360-365.
25. Veit G., Bossard F., Goepp J., Verkman A.S., Galietta L.J., Hanrahan J.W., Lukacs G.L. Proinflammatory cytokine secretion is suppressed by TMEM16A or CFTR channel activity in human cystic fibrosis bronchial epithelia. Mol. Biol. Cell 2012, 23:4188-4202.
26. - channels. Cell. Physiol. Biochem. 2011, 28:715-724.
27. Carles A., Millon R., Cromer A., Ganguli G., Lemaire F., Young J., Wasylyk C., Muller D., Schultz I., Rabouel Y., Dembele D., Zhao C., Marchal P., Ducray C., Bracco L., Abecassis J., Poch O., Wasylyk B. Head and neck squamous cell carcinoma transcriptome analysis by comprehensive validated differential display. Oncogene 2006, 25:1821-1831.
28. Huang X., Gollin S.M., Raja S., Godfrey T.E. High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:11369-11374.
29. West R.B., Corless C.L., Chen X., Rubin B.P., Subramanian S., Montgomery K., Zhu S., Ball C.A., Nielsen T.O., Patel R., Goldblum J.R., Brown P.O., Heinrich M.C., van de Rijn M. The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. Am. J. Pathol. 2004, 165:107-113.
30. -) channel, Ano1. Biochem. Biophys. Res. Commun. 2012, 427:248-253.
31. -) channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinoma. Cancer Lett. 2012, 326:41-51.
32. Ruiz C., Martins J.R., Rudin F., Schneider S., Dietsche T., Fischer C.A., Tornillo L., Terracciano L.M., Schreiber R., Bubendorf L., Kunzelmann K. Enhanced expression of ANO1 in head and neck squamous cell carcinoma causes cell migration and correlates with poor prognosis. PLoS One 2012, 7:e43265.
33. Duvvuri U., Shiwarski D.J., Xiao D., Bertrand C., Huang X., Edinger R.S., Rock J.R., Harfe B.D., Henson B.J., Kunzelmann K., Schreiber R., Seethala R.S., Egloff A.M., Chen X., Lui V.W., Grandis J.R., Gollin S.M. TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression. Cancer Res. 2012, 72:3270-3281.
34. Muselet-Charlier C., Roque T., Boncoeur E., Chadelat K., Clement A., Jacquot J., Tabary O. Enhanced IL-1beta-induced IL-8 production in cystic fibrosis lung epithelial cells is dependent of both mitogen-activated protein kinases and NF-kappaB signaling. Biochem. Biophys. Res. Commun. 2007, 357:402-407.
35. Bonvin E., Le Rouzic P., Bernaudin J.F., Cottart C.H., Vandebrouck C., Crie A., Leal T., Clement A., Bonora M. Congenital tracheal malformation in cystic fibrosis transmembrane conductance regulator-deficient mice. J. Physiol. 2008, 586:3231-3243.
36. Cai C., Rodepeter F.R., Rossmann A., Teymoortash A., Lee J.S., Quint K., DI Fazio P., Ocker M., Werner J.A., Mandic R. SIVmac(2)(3)(9)-Nef down-regulates cell surface expression of CXCR4 in tumor cells and inhibits proliferation, migration and angiogenesis. Anticancer Res. 2012, 32:2759-2768.
37. Namkung W., Phuan P.W., Verkman A.S. TMEM16A inhibitors reveal TMEM16A as a minor component of calcium-activated chloride channel conductance in airway and intestinal epithelial cells. J. Biol. Chem. 2011, 286:2365-2374.
38. Boncoeur E., Roque T., Bonvin E., Saint-Criq V., Bonora M., Clement A., Tabary O., Henrion-Caude A., Jacquot J. Cystic fibrosis transmembrane conductance regulator controls lung proteasomal degradation and nuclear factor-kappaB activity in conditions of oxidative stress. Am. J. Pathol. 2008, 172:1184-1194.
39. Saint-Criq V., Ruffin M., Rebeyrol C., Guillot L., Jacquot J., Clement A., Tabary O. Azithromycin fails to reduce inflammation in cystic fibrosis airway epithelial cells. Eur. J. Pharmacol. 2012, 674:1-6.
40. Rebeyrol C., Saint-Criq V., Guillot L., Riffault L., Corvol H., Chadelat K., Ray D.W., Clement A., Tabary O., Le Rouzic P. Glucocorticoids reduce inflammation in cystic fibrosis bronchial epithelial cells. Cell. Signal. 2012, 24:1093-1099.
41. Flamein F., Riffault L., Muselet-Charlier C., Pernelle J., Feldmann D., Jonard L., Durand-Schneider A.M., Coulomb A., Maurice M., Nogee L.M., Inagaki N., Amselem S., Dubus J.C., Rigourd V., Bremont F., Marguet C., Brouard J., de Blic J., Clement A., Epaud R., Guillot L. Molecular and cellular characteristics of ABCA3 mutations associated with diffuse parenchymal lung diseases in children. Hum. Mol. Genet. 2012, 21:765-775.
42. Blanchard E., Marie S., Riffault L., Bonora M., Tabary O., Clement A., Jacquot J. Reduced expression of Tis7/IFRD1 protein in murine and human cystic fibrosis airway epithelial cell models homozygous for the F508del-CFTR mutation. Biochem. Biophys. Res. Commun. 2011, 411:471-476.
43. Le Gars M., Descamps D., Roussel D., Saussereau E., Guillot L., Ruffin M., Tabary O., Hong S.S., Boulanger P., Paulais M., Malleret L., Belaaouaj A., Edelman A., Huerre M., Chignard M., Sallenave J.M. Neutrophil elastase degrades cystic fibrosis transmembrane conductance regulator via calpains and disables channel function in vitro and in vivo. Am. J. Respir. Crit. Care Med. 2013, 187:170-179.
44. Scudieri P., Caci E., Bruno S., Ferrera L., Schiavon M., Sondo E., Tomati V., Gianotti A., Zegarra-Moran O., Pedemonte N., Rea F., Ravazzolo R., Galietta L.J. Association of TMEM16A chloride channel overexpression with airway goblet cell metaplasia. J. Physiol. 2012, 590:6141-6155.
45. Blouquit S., Regnier A., Dannhoffer L., Fermanian C., Naline E., Boucher R., Chinet T. Ion and fluid transport properties of small airways in cystic fibrosis. Am. J. Respir. Crit. Care Med. 2006, 174:299-305.
46. Ogilvie V., Passmore M., Hyndman L., Jones L., Stevenson B., Wilson A., Davidson H., Kitchen R.R., Gray R.D., Shah P., Alton E.W., Davies J.C., Porteous D.J., Boyd A.C. Differential global gene expression in cystic fibrosis nasal and bronchial epithelium. Genomics 2011, 98:327-336.
47. -) conductance in cystic fibrosis. Biochim. Biophys. Acta 2011, 1812:1385-1392.
48. Bartoszewski R., Rab A., Jurkuvenaite A., Mazur M., Wakefield J., Collawn J.F., Bebok Z. Activation of the unfolded protein response by deltaF508 CFTR. Am. J. Respir. Cell Mol. Biol. 2008, 39:448-457.
49. Rab A., Bartoszewski R., Jurkuvenaite A., Wakefield J., Collawn J.F., Bebok Z. Endoplasmic reticulum stress and the unfolded protein response regulate genomic cystic fibrosis transmembrane conductance regulator expression. Am. J. Physiol. Cell Physiol. 2007, 292:C756-C766.
50. Blount A., Zhang S., Chestnut M., Hixon B., Skinner D., Sorscher E.J., Woodworth B.A. Transepithelial ion transport is suppressed in hypoxic sinonasal epithelium. Laryngoscope 2011, 121:1929-1934.
51. + channel activity control normal and cystic fibrosis bronchial epithelia repair. Am. J. Physiol. Lung Cell. Mol. Physiol. 2008, 295:L866-L880.
52. Wright C., Pilkington R., Callaghan M., McClean S. Activation of MMP-9 by human lung epithelial cells in response to the cystic fibrosis-associated pathogen Burkholderia cenocepacia reduced wound healing in vitro. Am. J. Physiol. Lung Cell. Mol. Physiol. 2011, 301:L575-L586.
53. Kirk K.L. CFTR channels and wound healing. Focus on "cystic fibrosis transmembrane conductance regulator is involved in airway epithelial wound repair". Am. J. Physiol. Cell Physiol. 2010, 299:C888-C890.
54. Stanich J.E., Gibbons S.J., Eisenman S.T., Bardsley M.R., Rock J.R., Harfe B.D., Ordog T., Farrugia G. Ano1 as a regulator of proliferation. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 301:G1044-G1051.
55. Schiller K.R., Maniak P.J., O'Grady S.M. Cystic fibrosis transmembrane conductance regulator is involved in airway epithelial wound repair. Am. J. Physiol. Cell Physiol. 2010, 299:C912-C921.